Introduction
Seborrheic dermatitis is a common skin condition that affects people of all ages. It is characterized by scaly, red patches of skin that are often itchy and uncomfortable. The exact cause of seborrheic dermatitis is unknown, but it is believed to be related to an overproduction of oil (sebum) from the sebaceous glands, as well as an overgrowth of a type of yeast known as Malassezia. This guide will provide an overview of seborrheic dermatitis, including its causes, symptoms, and treatment options.
Seborrheic dermatitis is a skin condition that is characterized by scaly, red patches of skin on the face, scalp, chest, and back. It is most common in adults, but can also occur in infants and children. The exact cause of seborrheic dermatitis is unknown, but it is believed to be related to an overproduction of oil (sebum) from the sebaceous glands, as well as an overgrowth of a type of yeast known as Malassezia.
Risk Factors for Seborrheic Dermatitis
There are a few factors that can increase the risk of developing seborrheic dermatitis. These include:
Age: Seborrheic dermatitis is most common in adults, but can also occur in infants and children.
Gender: Men are more likely to develop seborrheic dermatitis than women.
HIV/AIDS: People with HIV/AIDS are at an increased risk for developing seborrheic dermatitis.
Stress: Stress can make seborrheic dermatitis worse.
Weather: Cold, dry weather can make seborrheic dermatitis worse.
Medications: Certain medications can make seborrheic dermatitis worse.
Symptoms of Seborrheic Dermatitis
The most common symptom of seborrheic dermatitis is scaly, red patches of skin on the face, scalp, chest, and back. These patches may be itchy and uncomfortable. Other symptoms of seborrheic dermatitis include:
Dandruff: Seborrheic dermatitis can cause dandruff, which is a flaky, white or yellowish scalp buildup.
Hair loss: Seborrheic dermatitis can cause hair loss, especially in severe cases.
Oily skin: Seborrheic dermatitis can cause the skin to become oily and greasy.
Itching: Seborrheic dermatitis can cause itching and burning of the affected areas.
Diagnosis of Seborrheic Dermatitis
Seborrheic dermatitis is typically diagnosed based on a physical examination of the affected areas. The doctor may also take a skin sample to rule out other skin conditions, such as psoriasis or eczema.
Treatment of Seborrheic Dermatitis
Treatment for seborrheic dermatitis depends on the severity of the condition. Mild cases may be treated with over-the-counter anti-dandruff shampoos, such as those containing zinc pyrithione or salicylic acid. More severe cases may require prescription medications, such as topical corticosteroids or antifungal creams.
Prevention of Seborrheic Dermatitis
There are a few steps that can be taken to help prevent seborrheic dermatitis. These include:
Avoiding triggers: Identifying and avoiding triggers, such as stress, cold weather, and certain medications, can help reduce the risk of developing seborrheic dermatitis.
Shampooing regularly: Regular shampooing with an anti-dandruff shampoo can help reduce the risk of developing seborrheic dermatitis.
Moisturizing: Moisturizing the skin can help reduce the risk of developing seborrheic dermatitis.
1.
Researchers explore e-bikes for cancer recovery
2.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
3.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
4.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
5.
In inflammatory breast cancer, ER beta regulates estrogen signaling.
1.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
2.
Nuclear Medicine's Role in Battling Women's Cancers
3.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
4.
The benefits of using magnesium sulfate during pregnancy
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation